Short-term effects of atorvastatin on hemorheologic parameters and endothelial dysfunction in patients with hypercholesterolemia. Lower is better?

Clinical Hemorheology and Microcirculation

Volumn 40, Issue 4, 2008, Pages 325-326

  Habon, Tamas ^a   Horvath, Beata ^a   Szapary, Laszlo ^a   Toth, Kalman ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Atorvastatin; Endothelial function; Erythrocyte deformability; Hyperlipidaemia

Indexed keywords

ATORVASTATIN; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; TRIACYLGLYCEROL; VON WILLEBRAND FACTOR;

ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; BLOOD RHEOLOGY; BLOOD VISCOSITY; CEREBROVASCULAR DISEASE; ENDOTHELIAL DYSFUNCTION; ERYTHROCYTE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; LETTER; THROMBOCYTE AGGREGATION;

ADULT; ANTICHOLESTEREMIC AGENTS; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ERYTHROCYTE DEFORMABILITY; HEPTANOIC ACIDS; HUMANS; HYPERCHOLESTEROLEMIA; MIDDLE AGED; PLATELET AGGREGATION; PYRROLES; VON WILLEBRAND FACTOR;

EID: 58149392447     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: 10.3233/CH-2008-1141     Document Type: Letter

References (5)

1. C.P. Cannon, E. Braunwald, C.H. McCabe, D.J. Rader, J.L. Rouleau, R. Belder, S.V. Joyal, K.A. Hill, M.A. Pfeffer and A.M. Skene, Pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes, N. Engl. J. Med. 350 (2004), 1495-1504.
2. S.M. Grundy, J.I. Cleeman, C.N. Merz, H.B. Brewer, L.T. Clark, D.B. Hunninghake, R.C. Pasternak, S.C. Smith and N.J. Stone, Coordinating Committee of the National Cholesterol Education Program. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines, J. Am. Coll. Cardiol. 44 (2004), 720-732.
3. Heart Protection Study Collaborative Group, MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial, Lancet 360 (2002), 7-22.
4. L. Szapary, B. Horvath, Zs. Marton, T. Alexy, G. Kesmarky, T. Habon, M. Szots, K. Koltai, I. Juricskay, J. Czopf and K. Toth, Short term effect of low dose atorvastatin on hemorheological parameters, platelet aggregation and endothelial function in cerebrovascular patients with dyslipidemia, CNS Drugs 18 (2004), 165-172.
5. M. Uyuklu, H.J. Meiselman and O.K. Baskurt, Effect of decreased plasma cholesterol by atorvastatin treatment on erythrocyte mechanical properties, Clin. Hemorheol. Microcirc. 36 (2007), 25-33.